152771-01-2

Upstream product

• 81342-44-1 (2R,3R,4S,5R,6R)-2-(acetoxymethyl)-6-(2-(trimethylsilyl)ethoxy)tetrahydro-2H-pyran-3,4,5-triyl triacetate 
• 117253-03-9 2-(trimethylsilyl)ethyl 4,6-O-benzylidene-β-D-glucopyranoside 
• 81336-89-2 (2R,3S,4S,5R,6R)-2-(hydroxymethyl)-6-(2-(trimethylsilyl)ethoxy)tetrahydro-2H-pyran-3,4,5-triol 
• 117253-04-0 2-(trimethylsilyl)ethyl 2,3-di-O-benzyl-4,6-O-benzylidene-β-D-glucopyranoside 

Downstream Products

• 944060-16-6 C₂₈H₃₇Cl₃O₈Si 
• 152771-06-7 2-(Trimethylsilyl)ethyl 2,6-di-O-benzyl-6-deoxy-4-O-(2,3,4,6-tetra-O-acetyl-β-D-galactopyranosyl)-β-D-glucopyranoside 
• 152771-03-4 2-(Trimethylsilyl)ethyl 2,3-di-O-benzyl-6-deoxy-β-D-glucopyranoside 
• 174149-11-2 2-(trimethylsilyl)ethyl 2,3-di-O-benzyl-4-C-vinyl-6-O-(tert-butyldiphenylsilyl)-β-D-galactopyranoside 
• 174149-12-3 2-(trimethylsilyl)ethyl 2,3-di-O-benzyl-4-C-(hydroxymethyl)-6-O-(tert-butyldiphenylsilyl)-β-D-galactopyranoside 
• 174149-10-1 2-(trimethylsilyl)ethyl 2,3-di-O-benzyl-6-O-(tert-butyldiphenylsilyl)-β-D-xylo-hexoglucopyranosid-4-ulose 
• 174149-13-4 2-(trimethylsilyl)ethyl 4-C-(hydroxymethyl)-6-O-(tert-butyldiphenylsilyl)-β-D-galactopyranoside 
• 372518-39-3 5-[2-(2,2,2-trichloroethoxycarbonyl)aminoethyleneaminocarbonyl]pentyl (methyl 2,3-di-O-benzoyl-4-O-methyl-β-D-glucopyranosyl)uronate-(1->6)-2,3,4-tri-O-benzoyl-β-D-galactopyranoside 
• 372518-32-6 methyl (2,3-di-O-benzoyl-4-O-methyl-β-D-glucopyranosyl)uronate-(1->6)-2,3,4-tri-O-benzoyl-α-D-galactopyranosyl trichloroacetimidate 
• 372518-31-5 2-(trimethylsilyl)ethyl [methyl (2,3-di-O-benzoyl-4-O-methyl-β-D-glucopyranosyl)uronate]-(1->6)-2,3,4-tri-O-benzoyl-β-D-galactopyranoside 
• 372518-30-4 2-(trimethylsilyl)ethyl [methyl (2,3-di-O-benzoyl-4-O-methyl-β-D-glucopyranosyl)uronate]-(1->6)-2,3,4-tri-O-benzyl-β-D-galactopyranoside 
• 372518-27-9 methyl [2-(trimethylsilyl)ethyl 2,3-di-O-benzoyl-4-O-methyl-β-D-galactopyranoside]uronate 

Relevant academic research and scientific papers

Restriction of Conformation in Galabiosides Via an O6-O2′-Methylene Bridge

Treatment of 2-(trimethylsilyl)ethyl 2,3-di-O-acetyl-4-O-(3,4,6-tri-O-acetyl-α-D-galactopyranosyl)-β-D- galactopyranoside (12) and 2-(trimethylsilyl)ethyl 2,3-di-O-benzyl-β-D-glucopyranoside (15) with the novel reagent combination formaldehyde diphenylmer

Synthesis of a sialyl Lewis x mimic with fixed carboxylic acid group: Chemical approach toward the elucidation of the bioactive conformation of sialyl Lewis x

The relation of the solution and bioactive conformation of sialyl Lewis x (sLe(x)) has been addressed by chemical means. To mimic the preferred solution conformation of sLe(x) 1, the more rigid analog 2 has been designed and synthesized. The sialic acid r

Synthesis of the monodeoxy derivatives of 2-(trimethylsilyl)ethyl β-lactoside

Monodeoxy derivatives of 2-(trimethylsilyl)ethyl (Me3SiEt) β-lactoside were synthesized, by deoxygenation at the disaccharide level, for the 2'-, 3'-, 4'-, and 6'-monodeoxylactosides. The 2-, 3-, and 6-deoxy derivatives were synthesized by β-D-